University of California, San Diego clinical trial pipeline

8 trials changed in the last 30 days: 0 stopped, 5 with notable changes, 3 with minor changes only.

1. Notable

   Ovarian Reserve Testing in Female Young Adult Cancer Survivors

   Primary and study completion pushed from Dec 2026 to Dec 2028

   University of California, San Diego·Not applicable· NCT01421095· Registry history of NCT01421095 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

2. Notable

   Pramipexole to Enhance Social Connections

   Primary completion pushed from Mar 2026 to Nov 2026

   Also in this update: Trial status changed: Unknown → Active, Not Recruiting; Study completion pushed from Mar 2026 to Mar 2027

   University of California, San Diego·Phase 2· NCT06269146· Registry history of NCT06269146 on ClinicalTrials.gov (opens the registry)

   Sep 23, 2026

3. Notable

   MediNF · Meditative Neurofeedback for Depression

   Primary endpoint(s) modified

   Also in this update: Phase changed: not applicable → Phase 1; Enrollment increased: 27 → 60 participants

   University of California, San Diego·Phase 1· NCT06675240· Registry history of NCT06675240 on ClinicalTrials.gov (opens the registry)

   Oct 9, 2026

4. Notable

   Pembrolizumab Combined With Cetuximab · Recurrent/Metastatic Head…Pembrolizumab Combined With Cetuximab · Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

   Results posted: Oct 1, 2026

   University of California, San Diego·Phase 2· NCT03082534· Registry history of NCT03082534 on ClinicalTrials.gov (opens the registry)

   Oct 1, 2026

5. Notable

   Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation: A…Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation: A Department of Defense Funded Pragmatic Clinical Trial

   Results posted: Sep 24, 2026

   University of California, San Diego·Not applicable· NCT04713098· Registry history of NCT04713098 on ClinicalTrials.gov (opens the registry)

   Sep 24, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.